Please Wait
Applying Filters...
menu
    • menu
    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Virtual Booth

    Contact Supplier

    Axplora is your partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Onvansertib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 35,423Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cardiff Oncology Releases 2025 Results And Business Update
    Cardiff Oncology Releases 2025 Results And Business Update

    24 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/24/3244087/0/en/Cardiff-Oncology-Reports-Full-Year-2025-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    24 Feb 2026
    Share Share
    Cardiff Churns C-suite to Advance Cancer Candidate
    Cardiff Churns C-suite to Advance Cancer Candidate

    30 Jan 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/chutes-ladders-cardiff-churns-c-suite-advance-cancer-candidate

    FIERCE BIOTECH
    30 Jan 2026
    Share Share
    Cardiff Craters Amid Executive Exits, Mixed Mid-Stage Data
    Cardiff Craters Amid Executive Exits, Mixed Mid-Stage Data

    28 Jan 2026

    // BIOSPACE

    https://www.biospace.com/drug-development/cardiff-craters-amid-executive-exits-mixed-mid-stage-data

    BIOSPACE
    28 Jan 2026
    Share Share
    Cardiff Oncology Reports Positive Phase 2 Onvansertib Data
    Cardiff Oncology Reports Positive Phase 2 Onvansertib Data

    27 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/27/3226345/0/en/Cardiff-Oncology-Announces-Positive-Update-from-its-Randomized-Phase-2-Trial-of-Onvansertib-in-First-line-RAS-mutated-mCRC.html

    GLOBENEWSWIRE
    27 Jan 2026
    Share Share
    Cardiff Oncology Presents Onvansertib Data for CMML at ASH 2025
    Cardiff Oncology Presents Onvansertib Data for CMML at ASH 2025

    08 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/08/3201965/0/en/Cardiff-Oncology-Announces-Clinical-Data-from-Investigator-Sponsored-Trial-with-Onvansertib-in-Chronic-Myelomonocytic-Leukemia-at-ASH-2025.html

    GLOBENEWSWIRE
    08 Dec 2025
    Share Share
    Cardiff Oncology Reports Q3 2025 Results & Business Update
    Cardiff Oncology Reports Q3 2025 Results & Business Update

    06 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/06/3183076/0/en/Cardiff-Oncology-Reports-Third-Quarter-2025-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    06 Nov 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.